This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Each succeeding volume of reports of the Council reveals more of the long and successful fight in the interest of rational therapeutics. The Council is no longer chiefly concerned with noisome proprietaries and yet this latest volume contains reports on such articles as "Vita-Cell," a secret preparation marketed with exaggerated claims, and "Raylos," a shotgun preparation marketed in a way to promote its ill advised use by the public. Most of the "unacceptable" reports in this volume are concerned with products that may have some merit but are not offered to the public in a way which experience has taught the Council is necessary before a therapeutic agent is acceptable. Such products are Iodine Dusting Powder (Sulzberger), rejected for lack of clinical evidence of its advantage over one of its constituents; Pernoston, rejected because of lack of clinical evidence to justify routine intravenous injection of barbital compounds; Di-Hydranol, a claimed
Annual Reprints of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1934, with the Comments That Have Appeared in The Journal. JAMA. 1935;105(3):224. doi:10.1001/jama.1935.02760290058026
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: